{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:11:18Z","timestamp":1792271478103,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0006454","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000}}],"reference-count":129,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08AI121422-01A1"],"award-info":[{"award-number":["K08AI121422-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["GH5342"],"award-info":[{"award-number":["GH5342"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006454","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T14:00:43Z","timestamp":1526479243000},"page":"e0006454","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":55,"title":["Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0069-2372","authenticated-orcid":true,"given":"Philip J.","family":"Budge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0946-013X","authenticated-orcid":true,"given":"Britt J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-3824","authenticated-orcid":true,"given":"Gary J.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"e3328","DOI":"10.1371\/journal.pntd.0003328","article-title":"Global programme to eliminate lymphatic filariasis: the processes underlying programme success","volume":"8","author":"K Ichimori","year":"2014","journal-title":"PLoS neglected tropical diseases"},{"key":"ref2","year":"2006"},{"issue":"40","key":"ref3","first-page":"589","article-title":"Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion","volume":"92","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S1473-3099(05)70192-4","article-title":"Mass chemotherapy options to control lymphatic filariasis: a systematic review","volume":"5","author":"DJ Tisch","year":"2005","journal-title":"Lancet Infectious Diseases"},{"issue":"Suppl","key":"ref5","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1017\/S0031182000007423","article-title":"An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis","volume":"121","author":"J Horton","year":"2000","journal-title":"Parasitology"},{"issue":"4","key":"ref6","first-page":"Cd003753","article-title":"Albendazole for lymphatic filariasis","author":"J Critchley","year":"2005","journal-title":"The Cochrane database of systematic reviews"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14656566.6.2.179","article-title":"Treatment strategies underpinning the global programme to eliminate lymphatic filariasis","volume":"6","author":"JO Gyapong","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","article-title":"A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis","volume":"7","author":"A Krentel","year":"2013","journal-title":"PLoS neglected tropical diseases"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/civ882","article-title":"Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis","volume":"62","author":"EK Thomsen","year":"2016","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref10","unstructured":"WHO. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis. King JD, editor: WHO\/Department of control of neglected tropical diseases; 2017."},{"key":"ref11","unstructured":"Common terminology criteria for adverse events (CTCAE): National Cancer Institute; [cited 2018 3-21-18]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm\" xlink:type=\"simple\">https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm<\/ext-link>."},{"issue":"7","key":"ref12","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLOS Medicine"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0035-9203(91)90049-5","article-title":"Tolerance of single high-dose ivermectin for treatment of lymphatic filariasis","volume":"85","author":"DG Addiss","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0035-9203(96)90437-X","article-title":"Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine","volume":"90","author":"MM Ismail","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4269\/ajtmh.1991.44.3","article-title":"Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti","volume":"44","author":"FO Richards Jr.","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"16","key":"ref16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJM199004193221604","article-title":"A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis","volume":"322","author":"EA Ottesen","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0035-9203(95)90674-6","article-title":"Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine","volume":"89","author":"G Dreyer","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.trstmh.2005.07.016","article-title":"Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India","volume":"100","author":"BV Babu","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/clinids\/7.3.341","article-title":"Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans","volume":"7","author":"EA Ottesen","year":"1985","journal-title":"Rev Infect Dis"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0035-9203(87)90447-0","article-title":"Bancroftian filariasis in coastal north Trinidad: the effects of mass chemotherapy using spaced doses of diethylcarbamazine citrate on human microfilaraemias and vector infection rates","volume":"81","author":"MB Nathan","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref21","first-page":"111","article-title":"Effectiveness of spaced doses of diethylcarbamazine citrate for the control of bancroftian filariasis","volume":"40","author":"ML Eberhard","year":"1989","journal-title":"Trop Med Parasitol"},{"issue":"6","key":"ref22","first-page":"1097","article-title":"The efficacy of annual single-dose treatment with diethylcarbamazine citrate against diurnally subperiodic bancroftian filariasis in Samoa","volume":"63","author":"E Kimura","year":"1985","journal-title":"Bull World Health Organ"},{"issue":"3","key":"ref23","first-page":"395","article-title":"Purnomo, Partono F. Adverse reactions to a single dose of diethylcarbamazine in patients with Brugia malayi infection in Riau Province","volume":"16","author":"I Sutanto","year":"1985","journal-title":"West Indonesia. Southeast Asian J Trop Med Public Health"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/00034983.1993.11812796","article-title":"Jalajakumari. A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis","volume":"87","author":"RK Shenoy","year":"1993","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4269\/ajtmh.1993.49.804","article-title":"Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea","volume":"49","author":"J Kazura","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0035-9203(96)90534-9","article-title":"Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment","volume":"90","author":"DW Meyrowitsch","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref27","first-page":"9","article-title":"Combination ivermectin plus diethylcarbamazine, a new effective tool for control of lymphatic filariasis","volume":"46","author":"JP Moulia-Pelat","year":"1995","journal-title":"Trop Med Parasitol"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4269\/ajtmh.1994.50.206","article-title":"Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance","volume":"50","author":"JP Moulia-Pelat","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"ref29","first-page":"151","article-title":"Efficacy of a single dose treatment of Wuchereria bancrofti microfilaria carriers with diethylcarbamazine in Matara, Sri Lanka","volume":"43","author":"MV Weerasooriya","year":"1998","journal-title":"Ceylon Med J"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-3156.2000.00644.x","article-title":"Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India","volume":"5","author":"G Subramanyam Reddy","year":"2000","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0035-9203(95)90445-X","article-title":"Single-dose diethylcarbamazine in the control of periodic brugian filariasis in Peninsular Malaysia","volume":"89","author":"SL Hakim","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9097","key":"ref32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(97)07081-5","article-title":"Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes","volume":"351","author":"MJ Bockarie","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/infdis\/175.2.489","article-title":"Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia","volume":"175","author":"L Nicolas","year":"1997","journal-title":"J Infect Dis"},{"key":"ref34","first-page":"133","article-title":"Efficacy of two different DEC regimens in the treatment of human filarial infection","volume":"91","author":"GB Prasad","year":"1990","journal-title":"Indian J Med Res"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4269\/ajtmh.1995.53.267","article-title":"Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments","volume":"53","author":"PE Simonsen","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0035-9203(96)90484-8","article-title":"Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments","volume":"90","author":"DW Meyrowitsch","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref37","year":"2013"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0035-9203(99)90194-3","article-title":"Adverse reactions following diethylcarbamazine (DEC) intake in &apos;endemic normals&apos;, microfilaraemics and elephantiasis patients","volume":"93","author":"M Haarbrink","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref39","first-page":"72","article-title":"A study of ivermectin in the treatment of lymphatic filariasis due to Wuchereria bancrofti var. pacifica in French Polynesia","volume":"82","author":"J Roux","year":"1989","journal-title":"Bull Soc Pathol Exot Filiales"},{"issue":"21","key":"ref40","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1001\/jama.1988.03720210040026","article-title":"Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions","volume":"259","author":"V Kumaraswami","year":"1988","journal-title":"JAMA"},{"issue":"8540","key":"ref41","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(87)92291-4","article-title":"Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti","volume":"1","author":"S Diallo","year":"1987","journal-title":"Lancet"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-3156.1997.tb00157.x","article-title":"Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment","volume":"2","author":"WC Cao","year":"1997","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"1","key":"ref43","first-page":"80","article-title":"Ivermectin in the treatment of bancroftian filarial infection in Orissa, India","volume":"24","author":"SK Kar","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.1994.50.339","article-title":"Ivermectin treatment of bancroftian filariasis in Recife, Brazil","volume":"50","author":"AD Coutinho","year":"1994","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/0035-9203(91)90375-9","article-title":"A placebo-controlled double-blind trial for the treatment of bancroftian filariasis with ivermectin or diethylcarbamazine","volume":"85","author":"M Sabry","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref46","first-page":"71","article-title":"Treatment of bancroftian filariais with ivermectin in Sri Lanka: evaluation of efficacy and adverse reactions","volume":"8","author":"MM Ismail","year":"1991","journal-title":"Tropical Biomedicine"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0035-9203(94)90434-0","article-title":"Advantages of ivermectin at a single dose of 400 micrograms\/kg compared with 100 micrograms\/kg for community treatment of lymphatic filariasis in Polynesia","volume":"88","author":"NL Nguyen","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0035-9203(00)90135-4","article-title":"Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment","volume":"94","author":"SK Dunyo","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.trstmh.2003.12.005","article-title":"The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania","volume":"98","author":"PE Simonsen","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/infdis\/164.4.814","article-title":"Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin","volume":"164","author":"GJ Weil","year":"1991","journal-title":"J Infect Dis"},{"key":"ref51","article-title":"Stromectol (Ivermectin). Prescribing Information","year":"2010"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.1998.58.461","article-title":"Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis","volume":"58","author":"M Boussinesq","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"9070","key":"ref53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection","volume":"350","author":"J Gardon","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4269\/ajtmh.2005.73.115","article-title":"Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children","volume":"73","author":"LM Fox","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0035-9203(98)90972-5","article-title":"Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"92","author":"MM Ismail","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2883-1-1","article-title":"Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study","volume":"1","author":"S Pani","year":"2002","journal-title":"Filaria J"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4269\/ajtmh.14-0661","article-title":"The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo","volume":"92","author":"SD Pion","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(17)30175-5","article-title":"Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo","volume":"17","author":"SDS Pion","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref59","first-page":"19","article-title":". Treatment of bancroftian filariasis with albendazole: evaluation of efficacy and adverse reactions","volume":"10","author":"RL Jayakody","year":"1993","journal-title":"Tropical Biomedicine"},{"issue":"1","key":"ref60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1051\/parasite\/200209159","article-title":"Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia","volume":"9","author":"J Kamgno","year":"2002","journal-title":"Parasite"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"e0004492","DOI":"10.1371\/journal.pntd.0004492","article-title":"Effect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled Trial","volume":"10","author":"J Kamgno","year":"2016","journal-title":"PLoS neglected tropical diseases"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-308X(05)61010-X","article-title":"Lymphatic filariasis: Treatment, control and elimination","volume":"61","author":"EA Ottesen","year":"2006","journal-title":"Advances in parasitology"},{"issue":"1\u20132","key":"ref63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0001-706X(93)90045-D","article-title":"Side reactions following ivermectin therapy in high density bancroftian microfilaraemics","volume":"55","author":"SK Kar","year":"1993","journal-title":"Acta Trop"},{"issue":"5","key":"ref64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1179\/136485907X176517","article-title":"Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole","volume":"101","author":"JA Rizzo","year":"2007","journal-title":"Ann Trop Med Parasitol"},{"issue":"4","key":"ref65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4269\/ajtmh.1993.48.591","article-title":"Treatment of subperiodic Brugia malayi infection with a single dose of ivermectin","volume":"48","author":"JW Mak","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"ref66","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4269\/ajtmh.1992.46.745","article-title":"Renal abnormalities in microfilaremic patients with Bancroftian filariasis","volume":"46","author":"G Dreyer","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"ref67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/00034983.1992.11812664","article-title":"Jalajakumari. Ivermectin for the treatment of periodic malayan filariasis: a study of efficacy and side effects following a single oral dose and retreatment at six months","volume":"86","author":"RK Shenoy","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"issue":"5","key":"ref68","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/00034983.1998.11813315","article-title":"Treatment of microfilaraemia in asymptomatic brugian filariasis: the efficacy and safety of the combination of single doses of ivermectin and diethylcarbamazine","volume":"92","author":"RK Shenoy","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"ref69","first-page":"241","article-title":"Ivermectin for treatment of bancroftian filariasis in French Polynesia: efficacy in man, effect on transmission by vector Aedes polynesiensis","volume":"41","author":"JL Cartel","year":"1990","journal-title":"Trop Med Parasitol"},{"issue":"1","key":"ref70","first-page":"32","article-title":"Inappropriateness of the association of diphenhydramine with diethylcarbamazine for the treatment of lymphatic filariasis","volume":"92","author":"G Dreyer","year":"1989","journal-title":"J Trop Med Hyg"},{"issue":"2","key":"ref71","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4269\/ajtmh.1991.45.168","article-title":"Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations","volume":"45","author":"HJ Zheng","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"ref72","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2003.68.568","article-title":"Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000","volume":"68","author":"SI McLaughlin","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"ref73","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-3156.2002.00921.x","article-title":"Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae","volume":"7","author":"T Supali","year":"2002","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"3","key":"ref74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4269\/ajtmh.1969.18.369","article-title":"A filariasis-control program in American Samoa","volume":"18","author":"F Ciferri","year":"1969","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"ref75","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/00034983.1999.11813467","article-title":"Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations","volume":"93","author":"RK Shenoy","year":"1999","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"ref76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1590\/S0037-86822012000600017","article-title":"Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil","volume":"45","author":"AW Lima","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"ref77","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2004.70.191","article-title":"A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis","volume":"70","author":"M El Setouhy","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"ref78","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0035-9203(01)90257-3","article-title":"Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"95","author":"MM Ismail","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"ref79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0035-9203(97)90405-3","article-title":"Assessment of the efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo","volume":"91","author":"J Noroes","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0035-9203(98)90754-4","article-title":"Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti","volume":"92","author":"G Dreyer","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0035-9203(96)90138-8","article-title":"Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis","volume":"90","author":"J Figueredo-Silva","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"ref82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00034983.1992.11812684","article-title":"Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects","volume":"86","author":"PC Fan","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"ref83","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0035-9203(94)90241-0","article-title":"Double-blind controlled trial of a single dose of the combination ivermectin 400 micrograms\/kg plus diethylcarbamazine 6 mg\/kg for the treatment of bancroftian filariasis: results at six months","volume":"88","author":"P Glaziou","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"9076","key":"ref84","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(97)02231-9","article-title":"Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children","volume":"350","author":"DG Addiss","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"ref85","first-page":"335","article-title":"Single versus repeated doses of ivermectin and diethylcarbamazine for the treatment of Wuchereria bancrofti var. pacifica microfilaremia. Results at 12 months of a double-blind study","volume":"42","author":"JL Cartel","year":"1991","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"ref86","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0035-9203(01)90260-3","article-title":"Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India","volume":"95","author":"PK Das","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"ref87","doi-asserted-by":"crossref","first-page":"e0003583","DOI":"10.1371\/journal.pntd.0003583","article-title":"A randomized controlled trial of increased dose and frequency of albendazole with standard dose DEC for treatment of Wuchereria bancrofti microfilaremics in Odisha, India","volume":"9","author":"SK Kar","year":"2015","journal-title":"PLoS neglected tropical diseases"},{"issue":"3","key":"ref88","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0035-9203(84)90124-X","article-title":"Purnomo, Soewarta A, Oemijati S. Low dosage diethylcarbamazine administered by villagers for the control of timorian filariasis","volume":"78","author":"F Partono","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref89","article-title":"Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India","author":"NA Kshirsagar","year":"2017","journal-title":"Parasitol Res"},{"issue":"4","key":"ref90","first-page":"263","article-title":"Results of a safety trial on single-dose treatments with 400 mcg\/kg of ivermectin in bancroftian filariasis","volume":"43","author":"JL Cartel","year":"1992","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"ref91","first-page":"552","article-title":"Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province","volume":"90","author":"P Yongyuth","year":"2007","journal-title":"J Med Assoc Thai"},{"issue":"9","key":"ref92","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1365-3156.2008.02120.x","article-title":"Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka","volume":"13","author":"S Gunawardena","year":"2008","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"1","key":"ref93","first-page":"38","article-title":"Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months","volume":"42","author":"JL Cartel","year":"1991","journal-title":"Trop Med Parasitol"},{"issue":"2","key":"ref94","first-page":"79","article-title":"Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis","volume":"44","author":"JP Moulia-Pelat","year":"1993","journal-title":"Trop Med Parasitol"},{"issue":"3","key":"ref95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(95)90561-8","article-title":"Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis","volume":"89","author":"LD Andrade","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"ref96","first-page":"229","article-title":"The treatment of microfilaremia due to Wuchereria bancrofti var. pacifica: ivermectin versus diethylcarbamazine","volume":"71","author":"JL Cartel","year":"1991","journal-title":"Ann Soc Belg Med Trop"},{"issue":"3","key":"ref97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0035-9203(92)90312-Z","article-title":"Long-term suppression of microfilaraemia following ivermectin treatment","volume":"86","author":"ML Eberhard","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref98","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4269\/ajtmh.1993.48.178","article-title":"Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia","volume":"48","author":"DG Addiss","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"ref99","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4269\/ajtmh.2006.75.928","article-title":"Symptoms reported after mass drug administration for lymphatic filariasis in Leogane, Haiti","volume":"75","author":"N Hochberg","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"9296","key":"ref100","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(01)06899-4","article-title":"Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood","volume":"358","author":"HF Cross","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"ref101","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1084\/jem.191.8.1429","article-title":"Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria","volume":"191","author":"MJ Taylor","year":"2000","journal-title":"J Exp Med"},{"issue":"7","key":"ref102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-3024.2001.00400.x","article-title":"Wolbachia bacteria in filarial immunity and disease","volume":"23","author":"MJ Taylor","year":"2001","journal-title":"Parasite Immunol"},{"issue":"6","key":"ref103","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijpara.2004.02.001","article-title":"Construction of bacterial artificial chromosome libraries from the parasitic nematode Brugia malayi and physical mapping of the genome of its Wolbachia endosymbiont","volume":"34","author":"JM Foster","year":"2004","journal-title":"Int J Parasitol"},{"issue":"4","key":"ref104","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1371\/journal.pbio.0030121","article-title":"The Wolbachia genome of Brugia malayi: endosymbiont evolution within a human pathogenic nematode","volume":"3","author":"J Foster","year":"2005","journal-title":"PLoS Biol"},{"issue":"33","key":"ref105","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.M901528200","article-title":"Wolbachia lipoprotein stimulates innate and adaptive immunity through Toll-like receptors 2 and 6 to induce disease manifestations of filariasis","volume":"284","author":"JD Turner","year":"2009","journal-title":"J Biol Chem"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13071-014-0462-1","article-title":"Wolbachia lipoproteins: abundance, localisation and serology of Wolbachia peptidoglycan associated lipoprotein and the Type IV Secretion System component, VirB6 from Brugia malayi and Aedes albopictus","volume":"7","author":"D Voronin","year":"2014","journal-title":"Parasit Vectors"},{"issue":"9","key":"ref107","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1086\/586753","article-title":"Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment","volume":"46","author":"T Supali","year":"2008","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"8","key":"ref108","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/501351","article-title":"A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clinical infectious diseases: an official publication of the","volume":"42","author":"JD Turner","year":"2006","journal-title":"Infectious Diseases Society of America"},{"issue":"4","key":"ref109","first-page":"800","article-title":"A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis","volume":"41","author":"V Sanprasert","year":"2010","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"ref110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.2009.09-0155","article-title":"Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine","volume":"81","author":"S Mand","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"1\u20132","key":"ref111","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-1759(01)00370-2","article-title":"Comparative study of circulating immune complexes quantity detection by three assays\u2014CIF-ELISA, C1q-ELISA and anti-C3 ELISA","volume":"253","author":"SA Stanilova","year":"2001","journal-title":"J Immunol Methods"},{"issue":"3","key":"ref112","first-page":"245","article-title":"Microfilaraemia, filarial antibody, antigen and immune complex levels in human filariasis before, during and after DEC therapy. A two-year follow-up","volume":"45","author":"P Ramaprasad","year":"1988","journal-title":"Acta Trop"},{"issue":"2","key":"ref113","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4269\/ajtmh.1991.45.175","article-title":"Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment","volume":"45","author":"HJ Zheng","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"ref114","first-page":"465","article-title":"A single diethylcarbamazine dose for treatment of Wuchereria bancrofti carriers in French Polynesia: efficacy and side effects","volume":"21","author":"JL Cartel","year":"1990","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"5","key":"ref115","first-page":"307","article-title":"Comparative efficacy of annual and semi-annual doses of ivermectin or diethylcarbamazine for the prevention of lymphatic filariasis","volume":"40","author":"JL Cartel","year":"1992","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"4","key":"ref116","first-page":"240","article-title":"Tolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India","volume":"36","author":"SP Pani","year":"2004","journal-title":"The Journal of communicable diseases"},{"issue":"6","key":"ref117","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1179\/000349802125001663","article-title":"The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole","volume":"96","author":"RK Shenoy","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"ref118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2883-2-15","article-title":"Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis","volume":"2","author":"WH Makunde","year":"2003","journal-title":"Filaria J"},{"issue":"4","key":"ref119","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0035-9203(95)90049-7","article-title":"Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis","volume":"89","author":"G Dreyer","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"ref120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0035-9203(00)90278-5","article-title":"A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana","volume":"94","author":"SK Dunyo","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"ref121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0035-9203(03)00044-0","article-title":"Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India","volume":"98","author":"NA Kshirsagar","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"ref122","first-page":"402","article-title":"Abidha. Comparison of effects of mass annual and biannual single dose therapy with diethylcarbamazine for the control of Malayan filariasis","volume":"22","author":"KN Panicker","year":"1991","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"23","key":"ref123","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMoa021309","article-title":"Mass treatment to eliminate filariasis in Papua New Guinea","volume":"347","author":"MJ Bockarie","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"ref124","first-page":"128","article-title":"Hospital-based safety and tolerability study to assess efficacy of oral doxycycline in the treatment of Wuchereria bancrofti infection in north-eastern Tanzania","volume":"8","author":"WH Makunde","year":"2006","journal-title":"Tanzania health research bulletin"},{"issue":"9","key":"ref125","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-3156.2011.02814.x","article-title":"Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis","volume":"16","author":"F Anto","year":"2011","journal-title":"Tropical medicine & international health: TM & IH"},{"issue":"Suppl 1","key":"ref126","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.actatropica.2010.09.009","article-title":"Evaluation of effectiveness of diethylcarbamazine\/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters","volume":"120","author":"CN Wamae","year":"2011","journal-title":"Acta Trop"},{"issue":"11","key":"ref127","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1086\/657063","article-title":"Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels","volume":"51","author":"B Dembele","year":"2010","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref128","first-page":"i5078","article-title":"Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry\/journal editor perspective","volume":"355","author":"N Lineberry","year":"2016","journal-title":"BMJ (Clinical research ed)"},{"issue":"10","key":"ref129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: An extension of the consort statement","volume":"141","author":"JA Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0006454","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T23:54:14Z","timestamp":1571356454000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006454"}},"subtitle":[],"editor":[{"given":"Cinzia","family":"Cantacessi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":129,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006454","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0006454","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]}}}